|
|
|
Onconova Therapeutics (ONTX) CEO Steven Fruchtman at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Steven to moderate a Q&A session. NobleCon 17 Complete Rebroadcast
|
Onconova Therapeutics (ONTX) NobleCon17 Presentation Replay
